Primary Site >> Stomach Cancer
Gene >> REG4
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. PMID: 15132764 Ref: [Over expression of Reg IV in peritoneal dissemination of gastric cancer]. PMID: 15553756 |
Ref: Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma. PMID: 16086444 Ref: [Analysis of Reg IV expression in peritoneal dissemination of gastric cancer using real-time RT-PCR]. PMID: 16315915 |
Ref: Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. PMID: 17237819 |
Ref: Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis. PMID: 18505053 Ref: Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma. PMID: 18580680 |
Ref: Reg IV enhances peritoneal metastasis in gastric carcinomas. PMID: 19143768 Ref: Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. PMID: 19261089 Ref: Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers. PMID: 19329938 Ref: Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. PMID: 19670418 |
Ref: The role of Reg IV gene and its encoding product in gastric carcinogenesis. PMID: 19740514 Ref: Expression of Reg IV and Hath1 in neuroendocrine neoplasms. PMID: 19924642 Ref: Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. PMID: 20398667 Ref: Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin. PMID: 20403031 Ref: Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. PMID: 21443133 |
Ref: Evaluation of REG4 for early diagnosis and prognosis of gastric cancer. PMID: 21419474 Ref: Molecular pathology of gastric cancer: research and practice. PMID: 22005013 |
Ref: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. PMID: 22048633 Ref: Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-beta. PMID: 22430847 Ref: Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. PMID: 22929309 Ref: Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer. PMID: 23133598 |
Ref: Regenerating gene family member 4 promotes growth and migration of gastric cancer through protein kinase B pathway. PMID: 25356179 |
Ref: Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. PMID: 25517873 Ref: Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype. PMID: 26033320 |
Ref: REG4 promotes peritoneal metastasis of gastric cancer through GPR37. PMID: 27036049 |
Ref: Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway. PMID: 28759561 |
Ref: Expression of Reg IV and SOX9 and their correlation in human gastric cancer. PMID: 29587675 |